164 related articles for article (PubMed ID: 15280452)
1. Frequent transmission of cytotoxic-T-lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese population.
Furutsuki T; Hosoya N; Kawana-Tachikawa A; Tomizawa M; Odawara T; Goto M; Kitamura Y; Nakamura T; Kelleher AD; Cooper DA; Iwamoto A
J Virol; 2004 Aug; 78(16):8437-45. PubMed ID: 15280452
[TBL] [Abstract][Full Text] [Related]
2. HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding.
Couillin I; Connan F; Culmann-Penciolelli B; Gomard E; Guillet JG; Choppin J
Eur J Immunol; 1995 Mar; 25(3):728-32. PubMed ID: 7705402
[TBL] [Abstract][Full Text] [Related]
3. Molecular Basis for the Recognition of HIV Nef138-8 Epitope by a Pair of Human Public T Cell Receptors.
Ma K; Chai Y; Guan J; Tan S; Qi J; Kawana-Tachikawa A; Dong T; Iwamoto A; Shi Y; Gao GF
J Immunol; 2022 Nov; 209(9):1652-1661. PubMed ID: 36130828
[TBL] [Abstract][Full Text] [Related]
4. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
5. Different abilities of escape mutant-specific cytotoxic T cells to suppress replication of escape mutant and wild-type human immunodeficiency virus type 1 in new hosts.
Fujiwara M; Tanuma J; Koizumi H; Kawashima Y; Honda K; Mastuoka-Aizawa S; Dohki S; Oka S; Takiguchi M
J Virol; 2008 Jan; 82(1):138-47. PubMed ID: 17959671
[TBL] [Abstract][Full Text] [Related]
6. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
7. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
[TBL] [Abstract][Full Text] [Related]
8. Highly restricted T-cell receptor repertoire in the CD8+ T-cell response against an HIV-1 epitope with a stereotypic amino acid substitution.
Miyazaki E; Kawana-Tachikawa A; Tomizawa M; Nunoya J; Odawara T; Fujii T; Shi Y; Gao GF; Iwamoto A
AIDS; 2009 Mar; 23(6):651-60. PubMed ID: 19279440
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
Collins KL; Chen BK; Kalams SA; Walker BD; Baltimore D
Nature; 1998 Jan; 391(6665):397-401. PubMed ID: 9450757
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1.
Ikeda-Moore Y; Tomiyama H; Miwa K; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
J Immunol; 1997 Dec; 159(12):6242-52. PubMed ID: 9550428
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo.
Haas G; Plikat U; Debré P; Lucchiari M; Katlama C; Dudoit Y; Bonduelle O; Bauer M; Ihlenfeldt HG; Jung G; Maier B; Meyerhans A; Autran B
J Immunol; 1996 Nov; 157(9):4212-21. PubMed ID: 8892659
[TBL] [Abstract][Full Text] [Related]
12. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel HLA-B*2705-restricted cytotoxic T-lymphocyte epitope within a conserved region of HIV-1 Nef.
Goulder PJ; Edwards A; Phillips RE; McMichael AJ
AIDS; 1997 Mar; 11(4):536-8. PubMed ID: 9084804
[No Abstract] [Full Text] [Related]
14. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte epitope within HIV-1 Nef.
Goulder PJ; Edwards A; Phillips RE; McMichael AJ
AIDS; 1997 Dec; 11(15):1883-4. PubMed ID: 9412709
[No Abstract] [Full Text] [Related]
16. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.
Kiepiela P; Leslie AJ; Honeyborne I; Ramduth D; Thobakgale C; Chetty S; Rathnavalu P; Moore C; Pfafferott KJ; Hilton L; Zimbwa P; Moore S; Allen T; Brander C; Addo MM; Altfeld M; James I; Mallal S; Bunce M; Barber LD; Szinger J; Day C; Klenerman P; Mullins J; Korber B; Coovadia HM; Walker BD; Goulder PJ
Nature; 2004 Dec; 432(7018):769-75. PubMed ID: 15592417
[TBL] [Abstract][Full Text] [Related]
17. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
[TBL] [Abstract][Full Text] [Related]
18. HIV evolution: CTL escape mutation and reversion after transmission.
Leslie AJ; Pfafferott KJ; Chetty P; Draenert R; Addo MM; Feeney M; Tang Y; Holmes EC; Allen T; Prado JG; Altfeld M; Brander C; Dixon C; Ramduth D; Jeena P; Thomas SA; St John A; Roach TA; Kupfer B; Luzzi G; Edwards A; Taylor G; Lyall H; Tudor-Williams G; Novelli V; Martinez-Picado J; Kiepiela P; Walker BD; Goulder PJ
Nat Med; 2004 Mar; 10(3):282-9. PubMed ID: 14770175
[TBL] [Abstract][Full Text] [Related]
19. HLA-A*2402-restricted HIV-1-specific cytotoxic T lymphocytes and escape mutation after ART with structured treatment interruptions.
Tanuma J; Fujiwara M; Teruya K; Matsuoka S; Yamanaka H; Gatanaga H; Tachikawa N; Kikuchi Y; Takiguchi M; Oka S
Microbes Infect; 2008 May; 10(6):689-98. PubMed ID: 18462973
[TBL] [Abstract][Full Text] [Related]
20. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
